After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a new study.
People with COPD experience more falls and related injuries requiring medical care when using common ... Opioids, benzodiazepines and other medications used to treat these comorbidities and ...
People with COPD experience more falls and related injuries requiring medical care when using common ... Opioids, benzodiazepines and other medications used to treat these comorbidities and ...
“We are proud to continue advancing our asthma and COPD inhaled drug program ... patient access to vital therapies and address serious medical conditions with limited treatment options.